These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10500651)

  • 1. Comparison of cyclosporine immunoassays (AxSYM and RIA) for assessing pharmacokinetic parameters in liver transplant patients.
    Sabaté I; Lirón FJ; González Alba JM; Ginard M; Virgili J; Baró S; Figueras J; González Segura C; Jaurrieta E
    Transplant Proc; 1999 Sep; 31(6):2421-2. PubMed ID: 10500651
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral.
    Cantarovich M; Barkun J; Besner JG; Metrakos P; Alpert E; Deschénes M; Aalamian Z; Tchervenkov JI
    Transplant Proc; 1998 Jun; 30(4):1462-3. PubMed ID: 9636593
    [No Abstract]   [Full Text] [Related]  

  • 3. Area under the concentration curve values in pediatric liver transplant recipients on cyclosporin microemulsion formulation.
    Dunn SP; Kulinsky A; Falkenstein K; Pierson A; Chang CT; Cooney GF
    Transplant Proc; 1998 Aug; 30(5):1678-9. PubMed ID: 9723240
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group.
    Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
    Fisher RA; Pan SH; Rossi SJ; Schroeder TJ; Irish WD; Canafax DM; Lopez RR
    Transplant Proc; 1999; 31(1-2):394-5. PubMed ID: 10083157
    [No Abstract]   [Full Text] [Related]  

  • 6. Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients.
    Romagnoli J; Baiocchi L; Tisone G; Angelico M; Pisani F; Negrini S; Iaria G; Nistri A; Casciani CU
    Transplant Proc; 1996 Dec; 28(6):3129-30. PubMed ID: 8962212
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients.
    Barakat O; Peaston R; Rai R; Talbot D; Manas D
    Transplant Proc; 2002 Aug; 34(5):1535-7. PubMed ID: 12176472
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoral C2 monitoring in solid organ transplantation.
    Levy GA
    Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
    Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
    Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
    [No Abstract]   [Full Text] [Related]  

  • 12. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract]   [Full Text] [Related]  

  • 13. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine level: which single-point estimation of drug level is the best?
    Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M
    Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoral in liver transplantation.
    Levy GA; Grant D
    Transplant Proc; 1996 Apr; 28(2):1019-21. PubMed ID: 8623216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A is associated with a shift of the Th1/Th2 balance in liver transplant patients.
    van den Berg AP; Twilhaar WN; Corver K; Geerts AB; Mesander G; Klompmaker IJ; Slooff MJ; The TH; de Leij LH
    Transplant Proc; 1998 Aug; 30(5):2378-9. PubMed ID: 9723510
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient.
    Maeda Y; Kuzuya T; Ota S; Yamada K; Kobayashi T; Hayashi S; Yokoyama I; Nakao A; Nabeshima T
    Transplant Proc; 2002 Nov; 34(7):2784-7. PubMed ID: 12431611
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.
    Roessler E; Herrera S; Espinoza M; Ayala A; Reynolds E; González F; Espinoza O; Undurraga A; Muñoz R; Arcos O; Galaz G
    Transplant Proc; 1998 Aug; 30(5):1756-7. PubMed ID: 9723268
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF; Lum BL; Meligeni JA; Dunn SP
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract]   [Full Text] [Related]  

  • 20. Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation.
    Baraldo M; Risaliti A; Bresadola F; Chiarandini P; Dalla Rocca G; Furlanut M
    Transplant Proc; 2003 Jun; 35(4):1449-51. PubMed ID: 12826188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.